Thailand Clinical Laboratory Services Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2021 –2028 |
 Market Size (Base Year) |
USD 3,419.06 Million |
 Market Size (Forecast Year) |
USD 5,484.69 Million |
 CAGR |
% |
| Major Markets Players |
>泰国临床实验室服务市场，按服务类型（常规测试服务、深奥服务和解剖病理学服务）、专业（临床化学测试、血液学测试、微生物学测试、免疫学测试、滥用药物测试、细胞学测试和基因测试）、提供商（医院实验室、独立和参考实验室、临床实验室以及护理和医生办公室实验室）、应用（生物分析和实验室化学服务、药物开发相关服务、药物发现相关服务、毒理学测试服务、细胞和基因治疗相关服务、临床前和临床试验相关服务以及其他临床实验室服务）、国家（泰国）行业趋势和预测到 2028 年。
市场分析和见解：泰国临床实验室服务市场
泰国临床实验室服务市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，泰国临床实验室服务市场在 2021 年至 2028 年的预测期内以 6.2% 的复合年增长率增长，预计将从 2020 年的 34.1906 亿美元达到 2028 年的 54.8469 亿美元。传染病患病率的上升和对早期和准确诊断认识的提高是预测期内推动市场需求的主要驱动力。
临床实验室是医疗保健行业的重要组成部分。大多数诊断测试（从血液测试到基因分析）都是在这些临床实验室中进行的，以检测疾病。临床实验室提供数据和资源，以优化医疗保健系统中所需的分配，例如诊断和测试结果。这可以维护并提供可靠且正确的测试结果，使医生能够在各个级别的医疗保健服务中做出适当的临床和诊断决策。
数字病理学的日益普及进一步推动了对临床实验室服务的需求。泰国各地传染病的高发性以及人们对早期和准确诊断的认识不断提高，可能会推动临床实验室服务市场的增长。此外，不准确的测试结果和报销政策对市场构成了挑战。市场参与者的战略举措和不断增加的预防性健康检查为市场增长提供了机会。然而，缺乏熟练和认证的专业人员以及严格的监管政策限制了其在市场上的增长。
泰国临床实验室服务市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报；我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
泰国临床实验室服务市场范围和市场规模
泰国临床实验室服务市场根据服务类型、专业、提供商和应用进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据服务类型，泰国临床实验室服务市场分为常规检测服务、深奥服务和解剖病理学服务。由于肝病、心血管疾病和血液病等慢性病病例不断增加，预计 2021 年常规检测服务领域将占据市场主导地位。
- 根据专业领域，泰国临床实验室服务市场细分为临床化学检测、微生物学检测、血液学检测、基因检测、药物滥用检测和免疫学检测。2021 年，由于用于快速诊断疾病的即时检测解决方案的需求增加，临床化学检测领域预计将占据市场主导地位。
- 根据提供商，泰国临床实验室服务市场分为独立实验室和参考实验室、医院实验室以及护理和医生办公室实验室。2021 年，医院实验室部门预计将占据市场主导地位，因为医院受伤病例增加，导致患者数量和测试需求增加。
- 根据应用，泰国临床实验室服务市场细分为药物发现相关服务、药物开发相关服务、生物分析和实验室化学服务、毒理学检测服务、细胞和基因治疗相关服务、临床前和临床试验相关服务以及其他临床实验室服务。2021 年，生物分析和实验室化学服务领域预计将占据市场主导地位，因为生物分析是药物发现和开发的重要因素。
数字病理学平台的日益普及和临床实验室服务中慢性病的高发性为泰国临床实验室服务市场的参与者创造了新的机遇
泰国临床实验室服务市场还为您提供了详细的市场销售分析、泰国临床实验室服务市场发展的影响以及监管环境的变化及其对泰国临床实验室服务市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和泰国临床实验室服务市场份额分析
泰国临床实验室服务市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上数据点仅与公司对泰国临床实验室服务市场的关注有关。
泰国临床实验室服务报告涵盖的主要参与者包括 Eurofins Scientific、Siemens Healthcare GmbH、Abbott、Charles River Laboratories、Laboratory Corporation of America Holdings、Andalab Medical Laboratories、Brianet、SGS SA 和 Syneos Health 等国内和全球参与者。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
许多产品发布和协议也是由加速泰国临床实验室服务市场发展的公司发起的。
例如，
- 2021 年 6 月，Eurofins Scientific 宣布其子公司 Eurofins Clinical Testing US Holdings, Inc. 签署协议，收购消费者基因检测服务领域的领导者 Diagnostics Center (“DDC”)。此次收购有利于该公司扩大其在消费者基因检测领域的检测服务
- 2021 年 2 月，西门子医疗有限公司为高通量分析仪提供实验室抗原检测，并扩大了 COVID-19 检测能力。该公司的实验室 SARS-CoV-2 抗原检测 (CoV2Ag) 获得了 CE 标志；该检测将在 Atellica Solution 和 ADVIA Centaur 分析仪上提供，这些分析仪在全球实验室中广泛使用
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET BY SERVICE TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 THAILAND CLINICAL LABORATORY SERVICES MARKET CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
5.1 REGULATIONS IN THAILAND
5.2 REGULATIONS IN PHILIPPINES
5.3 REGULATIONS IN MALAYSIA
5.4 REGULATION IN INDONESIA
6 REIMBURSEMENT SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
7.1.2 ADVANCEMENTS IN CLINICAL DIAGNOSTIC METHODS
7.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
7.1.4 RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
7.1.5 RISING PER CAPITA INCOME
7.2 RESTRAINTS
7.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
7.2.2 STRICT REGULATORY POLICIES
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
7.3.2 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
7.3.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
7.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 INACCURATE RESULTS OF TESTS
7.4.2 INADEQUATE REIMBURSEMENTS POLICIES
8 IMPACT OF COVID-19
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
9.1 OVERVIEW
9.2 ROUTINE TESTING SERVICES
9.2.1 ROUTINE CHEMISTRY TESTING
9.2.2 ROUTINE HEMATOLOGY TESTING
9.2.3 URINALYSIS TESTING
9.2.4 SUBSTANCE ABUSE TESTING
9.2.5 OTHERS
9.3 ESOTERIC SERVICES
9.4 ANATOMIC PATHOLOGY SERVICES
9.4.1 CYTOLOGY TESTING
9.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
9.4.3 AUTOPSY PATHOLOGY
9.4.4 OTHERS
10 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
10.1 OVERVIEW
10.2 CLINICAL CHEMISTRY TESTING
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
10.2.3 SPECIALIZED CHEMISTRY TESTING
10.2.4 OTHER CLINICAL CHEMISTRY TESTING
10.3 HEMATOLOGY TESTING
10.3.1 ROUTINE HEMATOLOGY TESTING
10.3.2 SPECIALIZED HEMATOLOGY TESTING
10.3.3 COAGULATION TESTING
10.4 MICROBIOLOGY TESTING
10.4.1 INFECTIOUS DISEASE TESTING
10.4.2 TRANSPLANT DIAGNOSTIC TESTING
10.4.3 OTHER MICROBIOLOGY TESTING
10.5 IMMUNOLOGY TESTING
10.6 DRUGS OF ABUSE TESTING
10.7 CYTOLOGY TESTING
10.8 GENETIC TESTING
11 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
11.1 OVERVIEW
11.2 HOSPITAL-BASED LABORATORIES
11.3 INDEPENDENT & REFERENCE LABORATORIES
11.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
12 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
12.3 DRUG DEVELOPMENT RELATED SERVICES
12.4 DRUG DISCOVERY RELATED SERVICES
12.5 TOXICOLOGY TESTING SERVICES
12.6 CELL & GENE THERAPY RELATED SERVICES
12.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
12.8 OTHER CLINICAL LABORATORY SERVICES
13 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY
13.1 THAILAND
14 THAILAND CLINICAL LABORATORY SERVICES MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: THAILAND
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 ANDALAB MEDICAL LABORATORIES
16.2.1 COMPANY SNAPSHOT
16.2.2 SERVICE PORTFOLIO
16.2.3 RECENT DEVELOPMENT
16.3 BRIANET
16.3.1 COMPANY SNAPSHOT
16.3.2 SERVICE PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 CHARLES RIVER LABORATORIES
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 CITO CLINICAL LABORATORY
16.5.1 COMPANY SNAPSHOT
16.5.2 SERVICE PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 DAVITA INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 RECENT FINANCIALS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 EUROFINS SCIENTIFIC
16.7.1 COMPANY SNAPSHOT
16.7.2 RECENT FINANCIALS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 KERALTY
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 LABSERV INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 LABORATORY CORPORATION OF AMERICA® HOLDINGS
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 MAYON CLINICAL LABORATORIES
16.11.1 COMPANY SNAPSHOT
16.11.2 SERVICE PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MEDI LINX LABORATORY, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 QUEST DIAGNOSTICS INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SERVICE PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 PARAHITA DIAGNOSTIC CENTER
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PRODIA
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 PT KIMIA FARMA DIAGNOSTIKA
16.16.1 COMPANY SNAPSHOT
16.16.2 SERVICE PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 SGS SA
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENTS
16.18 SIEMENS HEALTHCARE GMBH
16.18.1 COMPANY SNAPSHOT
16.18.2 RECENT FINANCIALS
16.18.3 SERVICE PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 SUNWAY MED LAB
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 SYNEOS HEALTH
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 SERVICE PORTFOLIO
16.20.4 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 2 PRICE LIST OF VARIOUS HEMATOLOGY LABORATORY TESTINGS
TABLE 3 PRICE LIST OF VARIOUS SEROLOGY & IMMUNOLOGY LABORATORY TESTINGS
TABLE 4 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 5 THAILAND ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 6 THAILAND ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 7 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 8 THAILAND CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 9 THAILAND HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 THAILAND MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 11 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 12 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 14 THAILAND ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 15 THAILAND ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 16 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 17 THAILAND CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 18 THAILAND MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 19 THAILAND HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 20 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 THAILAND CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 2 THAILAND CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 THAILAND CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 THAILAND CLINICAL LABORATORY SERVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 THAILAND CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 THAILAND CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 THAILAND CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 THAILAND CLINICAL LABORATORY SERVICES MARKET SERVICE TYPE COVERAGE GRID
FIGURE 9 THAILAND CLINICAL LABORATORY SERVICES MARKET VENDOR SHARE ANALYSIS
FIGURE 10 THAILAND CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 REIMBURSEMENT POLICIES IN INDONESIA
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THAILAND CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BURDEN OF INFECTIOUS DISEASE IN SOUTHEAST ASIAN COUNTRIES
FIGURE 16 GROSS DOMESTIC PRODUCT (GDP) OF THE ASEAN COUNTRIES FROM 2000 TO 2018 (IN BILLION U.S. DOLLARS)
FIGURE 17 GDP PER CAPITA OF ASEAN COUNTRIES AS OF 2018
FIGURE 18 BENEFITS OF DIGITAL PATHOLOGY PLATFORMS
FIGURE 19 NUMBER OF COVID-19 TESTS IN SOUTHEAST ASIA AS OF 27 AUG, 2021
FIGURE 20 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 21 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021-2028 (USD MILLION)
FIGURE 22 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 23 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 24 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 25 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2021-2028 (USD MILLION)
FIGURE 26 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 27 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 28 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 29 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2021-2028 (USD MILLION)
FIGURE 30 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2021-2028)
FIGURE 31 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 32 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 33 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 34 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 35 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 THAILAND CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
